Development of active tuberculosis following initiation of infliximab despite appropriate prophylaxis [3]

Rheumatology

Volumn 46, Issue 5, 2007, Pages 887-888

  Raychaudhuri, S ^a,b   Shmerling, R ^a   Ermann, J ^a,b   Helfgott, S ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ETHAMBUTOL; INFLIXIMAB; ISONIAZID; LEFLUNOMIDE; LEVOFLOXACIN; METHOTREXATE; OXYCODONE; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN; SALAZOSULFAPYRIDINE; STEROID; WARFARIN; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG SENSITIVITY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPUTUM CULTURE; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; ANTIBIOTIC PROPHYLAXIS; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; LUNG TUBERCULOSIS; MIDDLE AGED; OPPORTUNISTIC INFECTION;

AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34347221973     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel447     Document Type: Letter

References (8)

1. Keane J, Gershon S, Wise RP et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
2. Keane J. TNF-blocking agents and tuberculosis: New drugs illuminate an old topic. Rheumatology (Oxford) 2005;44:714-20.
3. Smieja MJ, Marchetti CA, Cook DJ, Small FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000:CD001363.
4. Comstock GW, Baum C, Snider DE, Jr. Isoniazid prophylaxis among Alaskan Esidmos: A final report of the bethel isoniazid studies. Am Rev Respir Dis 1979;119:627-30.
5. Woldehanna S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2004:CD000171.
6. Westhovens R, Yocum D, Han J et al. The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: A large, randomized, placebo-controlled trial. Arthritis Rheum 2006;54:1075-86.
7. Carmona L, Gomez-Reino JJ, Rodriguez-Valverde V et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 2005;52:1766-72.
8. Parra Ruìz J, Ortego Centeno N, Raya Alvarez E. Development of tuberculosis in a patient treated with infibdmab who had received prophylactic therapy with isoniazid. J Rheumatol 2003;30:1657-8.